Istituto Superiore di Sanità-ko ikertzaileekin lankidetzan egindako argitalpenak (11)

2024

  1. Strategies to enhance the response of liver cancer to pharmacological treatments

    American journal of physiology. Cell physiology, Vol. 327, Núm. 1, pp. C11-C33

2021

  1. Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge

    Oncogene, Vol. 40, Núm. 23, pp. 4033-4049

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1

  2. Ethical criteria for the admission and management of patients in the icu under conditions of limited medical resources: A shared international proposal in view of the covid-19 pandemic

    Frontiers in Public Health, Vol. 8

2017

  1. Emerging clinical issues and multivariate analyses in PET investigations

    Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 61, Núm. 4, pp. 386-404

2015

  1. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

2014

  1. Classification of current anticancer immunotherapies

    Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508

  2. Consensus guidelines for the detection of immunogenic cell death

    OncoImmunology, Vol. 3, Núm. 9

2011

  1. Defining the critical hurdles in cancer immunotherapy

    Journal of Translational Medicine

2010

  1. Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1-3 October 2009

    Cancer Immunology, Immunotherapy